Determination of minimal transcriptional signatures of compounds for target prediction
暂无分享,去创建一个
Florian Nigsch | Janna Hutz | Ben Cornett | Douglas W. Selinger | Gregory McAllister | Somnath Bandyopadhyay | Joseph Loureiro | Jeremy L. Jenkins | D. Selinger | J. Jenkins | B. Cornett | Somnath Bandyopadhyay | J. Hutz | Gregory McAllister | J. Loureiro | Florian Nigsch
[1] J. Collins,et al. Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks , 2005, Nature Biotechnology.
[2] Darrell Whitley,et al. A genetic algorithm tutorial , 1994, Statistics and Computing.
[3] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[4] Gary D Bader,et al. The human genome and drug discovery after a decade. Roads (still) not taken , 2011, 1102.0448.
[5] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[6] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[7] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[8] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[9] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[10] Dorothea Emig,et al. Measuring and analyzing tissue specificity of human genes and protein complexes , 2011, EURASIP J. Bioinform. Syst. Biol..
[11] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[12] Angelo D. Favia,et al. Protein promiscuity and its implications for biotechnology , 2009, Nature Biotechnology.
[13] Peer Bork,et al. Drug-Induced Regulation of Target Expression , 2010, PLoS Comput. Biol..
[14] Dragos Horvath,et al. Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.
[15] M. Orešič,et al. Pathways to the analysis of microarray data. , 2005, Trends in biotechnology.
[16] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[17] Richard Morphy,et al. From magic bullets to designed multiple ligands. , 2004, Drug discovery today.
[18] J. Weinstein,et al. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data , 2002, The Pharmacogenomics Journal.
[19] Douglas W. Selinger,et al. Pathway Reporter Assays Reveal Small Molecule Mechanisms of Action , 2009 .
[20] Andreas Bender,et al. Ligand-Target Prediction Using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics , 2008, J. Chem. Inf. Model..
[21] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[22] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[23] Emanuel F Petricoin,et al. Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693 , 2010, BMC Genomics.